Adequate myocardial protection during cardiac surgery is essential to successful clinical outcomes. Despite a multitude of commercially available cardioplegic solutions, no clear consensus has been reached on the optimal composition or technique for using them. Currently there is a trend towards using myoprotective methods that extend the safe ischemic time, reducing the need for cardioplegia redosing. This is especially attractive in patients with valvular lesions where the administration of cardioplegia may require the use of specialized delivery cannulae or obscures the operative field, extending ischemic time. When minimally invasive techniques are employed, there is limited access to the coronary anatomy which reduces access for delivery and makes repeated dosing difficult. Such challenges have led to an evaluation of a newer generation of cardioplegic solution. Single dose cardioplegic techniques offer comfortable conditions, because it needs to be administered only once and protects the heart during the whole operation. Recently, specific data has become available for different single dose techniques and modes of cardiac surgery. Professor Szabo will shed light on the present state of studies with various cardioplegic methods and evaluate the clinical usefulness of each single dose cardioplegic solution.

We are looking forward to your participation!
Your team of the Köhler Campus

About the Event

Prof. Dr. med. GÁBOR SZABÓ, PhD

Professor and Director 
Department of Cardiovascular surgery, 
Martin-Luther-University Halle-Wittenberg (Saale), Germany 

Registration

This event is targeted at physicians and is free of charge.

Register to receive the link to the live webinar using the form below. To earn CME points, you are required to enter your EFN number. The CME points will be credited to your account within 3-4 weeks after your participation.